Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5775554

O=C(CCc1cnoc1-c1ccc(C(F)(F)F)cc1)NCCNc1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
GCGR P47871 2/20 0.40
TP53 P04637 2/20 0.38
FAAH O00519 1/20 0.38
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 1/20 0.37
TSHR P16473 1/20 0.37
KMT2A Q03164 1/20 0.37
HSD17B10 Q99714 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TRPV1 Q8NER1 4/20 0.37
FFAR1 O14842 2/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 1/20 0.36
PLAAT3 P53816 1/20 0.35
PLAAT5 Q96KN8 1/20 0.35
PLAAT2 Q9NWW9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5774844 0.91 HDAC4 (0.40) HDAC4HDAC1HDAC6TP53ALDH1A1
SCHEMBL5773606 0.85 MAPT (0.48) HDAC1TP53ALDH1A1MEN1TSHR
Trifluoroacetic Acid SCHEMBL5775717 0.85 GSK3B (0.44) TP53FAAHMEN1KMT2ATRPV1
Trifluoroacetic Acid SCHEMBL5776657 0.85 MAPT (0.42) HDAC4HDAC1HDAC6TP53TSHR
Trifluoroacetic Acid SCHEMBL5773866 0.83 ALDH1A1 (0.48) TP53ALDH1A1MEN1KMT2AL3MBTL1
Trifluoroacetic Acid SCHEMBL5772750 0.83 MAPT (0.40) FAAHALDH1A1TSHRTRPV1MAPT
Trifluoroacetic Acid SCHEMBL5774568 0.82 LMNA (0.50) TP53ALDH1A1MEN1KMT2AMAPT
Trifluoroacetic Acid SCHEMBL5774050 0.82 TRPV1 (0.43) HDAC1HDAC6TP53FAAHALDH1A1
Trifluoroacetic Acid SCHEMBL5773351 0.82 POLB (0.43) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
Trifluoroacetic Acid SCHEMBL5772665 0.82 NPC1 (0.52) HDAC4HDAC6TP53ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR HDAC4 434/4885HDAC1 353/4885HDAC6 1324/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 HDAC4 497/4885HDAC1 184/4885HDAC6 1224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.